文献速递心力衰竭与心肌病血脂与心血管预防

心血管遗传学:基因检测在肥厚型心肌病诊疗中的作用

Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy.
PubMed 文献 · Heart · 2020-11-10

综述阐述基因检测在肥厚型心肌病(HCM)管理中的价值:可辅助诊断、鉴别其他导致左室壁增厚的疾病,并识别高危亲属以指导家族管理。对临床确诊患者推荐靶向基因面板检测,若发现致病/可能致病变异,推荐对高危亲属进行预测性检测。文章还讨论遗传咨询及结果解读的复杂性。

要点

  • 临床确诊HCM后推荐靶向基因面板检测,以明确病因并鉴别其他左室壁增厚疾病。
  • 检出致病/可能致病变异时,推荐对高危亲属进行预测性基因检测以指导筛查。
  • 基因检测前后需遗传咨询,结果解读需专业经验评估临床相关性。

核心结论

  • 基因检测是管理HCM患者及其家族的有价值工具,可辅助诊断、鉴别诊断并识别高危亲属。

研究设计与样本

  • 本文为综述,讨论HCM的遗传学及如何在临床实践中整合基因检测。

主要发现

  • 基因检测可帮助鉴别HCM与其他导致左室壁增厚的疾病,直接影响治疗。
  • 基因检测可明确识别高危亲属,聚焦家族管理。
  • 已发现肌节及肌节相关基因的致病变异导致HCM,临床确诊后推荐靶向基因面板检测。
  • 若患者检出致病/可能致病变异,推荐对其高危亲属进行预测性基因检测以确定风险并指导纵向筛查和风险分层。

关键数值与推荐

  • 临床确诊HCM后推荐靶向基因面板检测。
  • 患者检出致病/可能致病变异时,推荐对高危亲属进行预测性基因检测。

临床怎么用

  • 临床确诊HCM后应启动基因检测,以辅助鉴别诊断和家族筛查。
  • 检出致病变异后应进行家族级联检测,确定高危亲属并指导纵向筛查与风险分层。
  • 基因检测前后应提供遗传咨询,关注心理影响并专业解读结果临床相关性。

局限性

  • 基因检测结果对患者及家庭有心理及其他影响,需遗传咨询。
  • 确定基因检测结果的临床相关性复杂,需人类遗传变异和疾病临床表现的专业知识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Genetic testing in hypertrophic cardiomyopathy (HCM) is a valuable tool to manage patients and their families. Genetic testing can help inform diagnosis and differentiate HCM from other disorders that also result in increased left ventricular wall thickness, thereby directly impacting treatment. Moreover, genetic testing can definitively identify at-risk relatives and focus family management. Pathogenic variants in sarcomere and sarcomere-related genes have been implicated in causing HCM, and targeted gene panel testing is recommended for patients once a clinical diagnosis has been established. If a pathogenic or likely pathogenic variant is identified in a patient with HCM, predictive genetic testing is recommended for their at-risk relatives to determine who is at risk and to guide longitudinal screening and risk stratification. However, there are important challenges and considerations to implementing genetic testing in clinical practice. Genetic testing results can have psychological and other implications for patients and their families, emphasising the importance of genetic counselling before and after genetic testing. Determining the clinical relevance of genetic testing results is also complex and requires expertise in understanding of human genetic variation and clinical manifestations of the disease. In this review, we discuss the genetics of HCM and how to integrate genetic testing in clinical practice.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ahluwalia M, Ho CY. Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy. Heart. 2020. PMID: 33172912. doi:10.1136/heartjnl-2020-316798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。